Phosphorylation of Vif and its role in HIV-1 replication.
Vif is a 23-kDa protein encoded by human immunodeficiency virus, type 1 (HIV-1) which is important for virion infectivity. Here, we describe the phosphorylation of HIV-1 Vif and its role in HIV-1 replication. In vivo studies demonstrated that Vif is highly phosphorylated on serine and threonine residues. To identify phosphorylation sites and characterize the Vif kinase(s), Vif was expressed in Escherichia coli and purified for use as a substrate in in vitro kinase assays. The purified Vif protein was phosphorylated in vitro on serine and threonine residues by a kinase(s) present in both cytosol and membrane fractions. Phosphorylation of Vif was stimulated by phorbol 12-myristate 13-acetate and inhibited by staurosporine and hypericin, a drug with potent anti-HIV activity. The Vif kinase(s) was resistant to inhibitors of protein kinase C, cAMP-dependent kinase, and cGMP-dependent kinase, suggesting that it is distinct from these enzymes. To identify the phosphorylation sites, 32P-labeled Vif was digested by V8 protease and the peptides were resolved by reverse-phase high performance liquid chromatography. Radioactive peptide sequencing identified three phosphorylation sites within the C terminus, Ser144, Thr155, and Thr188. Two-dimensional tryptic phosphopeptide mapping indicated that these sites are also phosphorylated in vivo. Both Ser144 and Thr188 are contained in the recognition motifs (R/KXXS*/T* and R/KXXXS*/T*) used by serine/threonine protein kinases such as cGMP-dependent kinase and PKC. Ser144 is present in the motif SLQXLA, which is the most highly conserved sequence among all lentivirus Vif proteins. Mutation of Ser144 to alanine resulted in loss of Vif activity and >90% inhibition of HIV-1 replication. These studies suggest that phosphorylation of Vif by a serine/threonine protein kinase(s) plays an important role in regulating HIV-1 replication and infectivity.
Yang
X
X
Division of Human Retrovirology, Dana-Farber Cancer Institute and the Departments of Pathology and Neurology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Goncalves
J
J
Gabuzda
D
D
D000470:Alkaloids / Q000494:pharmacology; D000595:Amino Acid Sequence; D001483:Base Sequence; D002478:Cells, Cultured; D017931:DNA Primers / Q000737:chemistry; D004791:Enzyme Inhibitors / Q000494:pharmacology; D016346:Gene Products, vif / Q000378:metabolism*; D005816:Genetic Complementation Test; D015497:HIV-1 / Q000254:growth & development* / Q000472:pathogenicity; D006801:Humans; D008969:Molecular Sequence Data; D010449:Peptide Mapping; D010766:Phosphorylation; D010768:Phosphoserine / Q000378:metabolism; D010769:Phosphothreonine / Q000378:metabolism; D017354:Point Mutation; D047428:Protein Kinase Inhibitors; D011994:Recombinant Proteins; D019311:Staurosporine; D013329:Structure-Activity Relationship; D014779:Virus Replication; D054320:vif Gene Products, Human Immunodeficiency Virus
D000470:Alkaloids; D017931:DNA Primers; D004791:Enzyme Inhibitors; D016346:Gene Products, vif; D047428:Protein Kinase Inhibitors; D011994:Recombinant Proteins; D054320:vif Gene Products, Human Immunodeficiency Virus; D010769:Phosphothreonine; D010768:Phosphoserine; D019311:Staurosporine